Linda Julia Morcombe Bryant ONZM is a New Zealand clinical pharmacist. Bryant was awarded a Gold Medal by the Pharmaceutical Society in 2019, and in 2022 she was appointed as an Officer of the New Zealand Order of Merit for services to pharmacy and health.

Linda Bryant
Bryant in 2022
AwardsPharmaceutical Society of New Zealand Gold Medal Award, Officer of the New Zealand Order of Merit
Academic background
Theses
  • Effect of a medicines information bulletin / and or a pharmacist facilitator on general practitioner prescribing (1993)
  • Evaluation of the barriers to, and implementation of, comprehensive pharmaceutical care in New Zealand (2006)
Academic work
InstitutionsUniversity of Auckland
Doctoral studentsNatalie Gauld

Career

edit

Bryant is a clinical pharmacist and a prescribing pharmacist. She began working as a hospital pharmacist before moving into primary care.[1] Bryant completed a Master of Pharmacy titled Effect of a medicines information bulletin / and or a pharmacist facilitator on general practitioner prescribing at the University of Otago.[2] She went on to complete a PhD at the University of Auckland, with a thesis on the barriers to and implementation of a comprehensive pharmaceutical care in New Zealand.[3] Bryant lectured at the University of Otago for more than 20 years, and was also an honorary lecturer at the University of Auckland.[4] One of Bryant's notable doctoral students is pharmacist Natalie Gauld.[5]

Bryant was a founder of the Clinical Advisory Pharmacists Association, in 2003, and served as President from 2014 to 2017.[4]

Honours and awards

edit

In 2017 Bryant was awarded an Innovation in Teaching Award at the University of Otago Green Cross Health Pharmacy Awards.[6] Bryant was awarded a Gold Medal by the Pharmaceutical Society in 2019.[7] In 2020 she was awarded the Outstanding Contribution to Health award at the New Zealand Primary Healthcare Awards.[8] She is also a Fellow of the New Zealand Hospital Pharmacists Association, and the New Zealand College of Pharmacists.[1]

In the 2022 New Year's Honours Bryant was appointed as an Officer of the New Zealand Order of Merit for services to pharmacy and health.[7]

Selected works

edit
  • Vanessa Selak; C Raina Elley; Chris Bullen; et al. (27 May 2014). "Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care". The BMJ. 348: g3318. doi:10.1136/BMJ.G3318. ISSN 0959-8138. PMID 24868083. Wikidata Q42662673.
  • Linda J M Bryant; Gregor Coster; Greg D Gamble; Ross N McCormick (25 April 2009). "General practitioners' and pharmacists' perceptions of the role of community pharmacists in delivering clinical services". Research in Social and Administrative Pharmacy. 5 (4): 347–362. doi:10.1016/J.SAPHARM.2009.01.002. ISSN 1551-7411. PMID 19962678. Wikidata Q39922507.
  • Linda J M Bryant; Gregor Coster; Greg D Gamble; Ross N McCormick (25 February 2011). "The General Practitioner-Pharmacist Collaboration (GPPC) study: a randomised controlled trial of clinical medication reviews in community pharmacy". International Journal of Pharmacy Practice. 19 (2): 94–105. doi:10.1111/J.2042-7174.2010.00079.X. ISSN 0961-7671. PMID 21385240. Wikidata Q37850830.
  • Vanessa Selak; C Raina Elley; Sue Crengle; et al. (18 July 2011). "IMProving Adherence using Combination Therapy (IMPACT): design and protocol of a randomised controlled trial in primary care". Contemporary Clinical Trials. 32 (6): 909–915. doi:10.1016/J.CCT.2011.07.006. ISSN 1551-7144. PMID 21777702. Wikidata Q43810565.
  • Nataly Martini; Linda Bryant; Leanne Te Karu; et al. (1 April 2012). "Living with gout in New Zealand: an exploratory study into people's knowledge about the disease and its treatment". Journal of Clinical Rheumatology. 18 (3): 125–129. doi:10.1097/RHU.0B013E31824E1F6F. ISSN 1076-1608. PMID 22426580. Wikidata Q46834862.
  • Natalie Gauld; Fiona Kelly; Nahoko Kurosawa; Linda J M Bryant; Lynne M Emmerton; Stephen Buetow (24 September 2014). "Widening consumer access to medicines through switching medicines to non-prescription: a six country comparison". PLOS One. 9 (9): e107726. Bibcode:2014PLoSO...9j7726G. doi:10.1371/JOURNAL.PONE.0107726. ISSN 1932-6203. PMC 4175460. PMID 25251434. Wikidata Q34245674.

References

edit
  1. ^ a b "CAPA Board: Linda Bryant – Previous Chair". Clinical Advisory Pharmacists Association. Retrieved 8 October 2024.
  2. ^ Bryant, Linda M. (1993). Effect of a medicines information bulletin / and or a pharmacist facilitator on general practitioner prescribing (Master of Pharmacy (clinical pharmacy) thesis). University of Otago.
  3. ^ Bryant, Linda (2006). Evaluation of the barriers to, and implementation of, comprehensive pharmaceutical care in New Zealand (PhD thesis thesis). University of Auckland.
  4. ^ a b Chilton-Towle, Jonathan (11 May 2022). "Pharmacy pioneer awarded New Year Honour". Pharmacy Today.
  5. ^ Gauld, Natalie Joan (2013). How and why do developed countries vary in reclassifying medicines from prescription to non-prescription? (PhD thesis). ResearchSpace@Auckland, University of Auckland. hdl:2292/21782.
  6. ^ "Green Cross Health Pharmacy Awards Ceremony". University of Otago. 18 August 2017. Retrieved 8 October 2024.
  7. ^ a b "New Year Honours 2022 - Citations for Officers of the New Zealand Order of Merit | Department of the Prime Minister and Cabinet (DPMC)". www.dpmc.govt.nz. 31 December 2021. Retrieved 8 October 2024.
  8. ^ "Pharmacist awarded Royal Honour". Pharmaceutical Society of New Zealand. 2022. Retrieved 8 October 2024.
edit